SOST and anorexia nervosa: In contrast to adolescents with anorexia nervosa, in whom 12 months of treatment with transdermal estrogen did not result in significant changes in sclerostin levels,39 we found that 3 months of transdermal estrogen significantly lowered sclerostin levels, and that this decrease in sclerostin was associated with increases in lateral spine BMD.